NMD4C steering committee
The Steering Committee provides overall scientific leadership, direction, and oversight. Its members are responsible for overseeing progress and coordination between the different work strands, operations, administration, budget, and interaction with knowledge users. They are accountable for the delivery of the scientific milestones and the effective administration of the project.
Dr Hanns Lochmüller leads the NMD4C network. He is a neurologist and clinical academic specializing in neuromuscular disorders. He is Senior Scientist at the Children’s Hospital of Eastern Ontario (CHEO) Research Institute and Professor of Neurology at the University of Ottawa and the Division of Neurology at The Ottawa Hospital.
Dr James Dowling is Associate Professor of Paediatrics and Molecular Genetics at the University of Toronto, and a Neurologist and Senior Scientist at the Hospital for Sick Children. He represents paediatric NMDs as a member of the NMD4C Steering Committee, leads on genomics education and curriculum, and participates in trial coordination.
Dr Jodi Warman Chardon is Assistant Professor of Neurology at University of Ottawa, Director of the Ottawa Hospital Neuromuscular Centre and co-Director of the uOttawa Centre for Neuromuscular Disease. She represents adult NMDs on the NMD4C Steering Committee and participates in genomics education.
Dr Rashmi Kothary is the Deputy Scientific Director and Senior Scientist at the Ottawa Hospital Research Institute (OHRI). He represents basic science as a member of the NMD4C Steering Committee.
Barbara Stead-Coyle is Chief Executive Officer of Muscular Dystrophy Canada. She is an experienced professional in not-for-profit organizations and represents MDC on the NMD4C Steering Committee.
Canada’s leading institutions and investigators in neuromuscular clinical and scientific research take responsibility in NMD4C in close partnership with knowledge users from MDC and other patient organisations representing a wide range of neuromuscular diseases. The network will expand during the course of the project as additional professionals sign up to participate in the work.
Dr Bernard Brais is Professor of Neurology and Human Genetics at McGill University in Montreal and co-director of the Montreal Neurological Institute’s Rare Neurological Diseases Group. His lab has focused on identifying new genes and mutations that cause hereditary diseases that are more prevalent in the French Canadian population of Quebec due to founder effects.
Dr Craig Campbell is affiliated with the Thames Valley Children’s Centre and the Pediatric Neurophysiology Laboratory at Children’s Hospital London Health Sciences Centre. He is an Associate Professor in Pediatrics, Clinical Neurological Sciences and Epidemiology at Western University and a Scientist at the Children’s Health Research Institute.
Dr Cynthia Gagnon is a professor at the School of Rehabilitation at the University of Sherbrooke and a researcher at the Centre de recherche Charles-Le Moyne-Saguenay-Lac-St-Jean sur les innovations en santé. Her work aims at improving clinical care and speeding up trial readiness in the most prevalent neuromuscular diseases in Canada. Within NMD4C, Cynthia is lead for knowledge translation.
Dr Hugh McMillan is an Associate Professor of Pediatrics at the University of Ottawa, a Pediatric Neurologist and Neuromuscular specialist at the Children’s Hospital of Eastern Ontario (CHEO) and a Clinical Investigator at the CHEO Research Institute.
Dr Kathryn Selby is Clinical Assistant Professor at the University of British Columbia, Medical Director of the pediatric neuromuscular program of BC and the Yukon, and an investigator at BC Children’s Hospital Research Institute.
Dr Lawrence Korngut is a neurologist, clinical neurophysiologist and Director of the Calgary Neuromuscular Program and the Calgary ALS and Motor Neuron Disease Clinic. He is the former chair of the CAN-NMD network and is involved in the NMD4C work on trial capacity building.
Dr Maryam Oskoui is an Associate Professor in the Departments of Pediatrics and Neurology and Neurosurgery at McGill University and Associate Member of the Department of Epidemiology and Biostatistics.
Perry Esler is Executive Director of Jesse’s Journey, Canada’s largest Duchenne-focused charity. He works as part of the NMD4C knowledge user group with a focus on knowledge translation for Duchenne families.
Dr Reshma Amin is Associate Professor at the University of Toronto; Respirologist and Sleep Physician at SickKids; and Associate Scientist, Child Health and Evaluative Sciences at SickKids Research Institute. Within NMD4C Reshma is working on the development of clinical care guidelines for NMDs and patient advocacy training modules for NMD.
Teresa Buffone leads the Ottawa-Gatineau Myotonic Dystrophy Support Group and is an advocate for the US Myotonic Dystrophy Foundation. Within NMD4C she works with MDC and other knowledge user representatives on knowledge translation to the patient community.
Do you have a passion for research and care in neuromuscular diseases and the difference it can make for Canadian patients? We are recruiting network staff and are always keen to have new academic and patient organization members.